simvastatin has been researched along with Coronary Artery Stenosis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, BG; Cheung, MC; Dobiásová, M; Frohlich, J; Sedová, M | 1 |
| Bavendiek, U; Ganz, P; Gerdes, N; Horton, DB; Kinlay, S; Libby, P; Reynolds, RS; Robbie, L; Schönbeck, U; Varo, N | 1 |
| Asztalos, BF; Batista, M; Brown, GB; Cox, CE; Dallal, GE; Horvath, KV; Morse, JS; Schaefer, EJ | 1 |
| Dendorfer, A; Dominiak, P; Heep, A; Klein, HH; Richardt, G; Schutt, M; Tempel, K; Weidtmann, B; Wolfrum, S | 1 |
| Anderson, JL; Horne, BD; Lappe, DL; Maycock, CA; Meredith, KG; Muhlestein, JB; Pearson, RR | 1 |
| Gawaz, M; Geisler, T; Paterok, M; Zürn, CS | 1 |
| Alaupovic, P; Albers, JJ; Bolson, EL; Brown, BG; Chait, A; Cheung, MC; Dowdy, AA; Fisher, LD; Frohlich, J; Marino, EK; Morse, JS; Zhao, XQ | 1 |
| Freedman, JE | 1 |
5 trial(s) available for simvastatin and Coronary Artery Stenosis
| Article | Year |
|---|---|
Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography.
Topics: Antioxidants; Apolipoproteins B; Atherosclerosis; Cholesterol; Coronary Angiography; Coronary Stenosis; Drug Combinations; Esterification; Humans; Lipoproteins; Niacin; Particle Size; Simvastatin | 2011 |
Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.
Topics: Animals; Atorvastatin; Blood Coagulation; CD40 Antigens; CD40 Ligand; Cells, Cultured; Cohort Studies; Coronary Stenosis; Cytokines; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocytes, Mononuclear; Lipoproteins, LDL; Male; Mice; Middle Aged; Muscle, Smooth, Vascular; Phagocytes; Pyridines; Pyrroles; RNA, Messenger; Simvastatin | 2002 |
Change in alpha1 HDL concentration predicts progression in coronary artery stenosis.
Topics: Aged; Antioxidants; Apolipoprotein A-I; Apolipoprotein A-II; Coronary Stenosis; Disease Progression; Electrophoresis, Agar Gel; Female; Humans; Lipids; Lipoproteins, HDL; Male; Middle Aged; Niacin; Particle Size; Radiography; Simvastatin; Treatment Outcome; Vitamins | 2003 |
Comparison of effects of high (80 mg) versus low (20 mg) dose of simvastatin on C-reactive protein and lipoproteins in patients with angiographic evidence of coronary arterial narrowing.
Topics: Aged; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Stenosis; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Male; Prospective Studies; Simvastatin; Treatment Outcome | 2007 |
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
Topics: alpha-Tocopherol; Antioxidants; Apolipoproteins; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Disease; Coronary Stenosis; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipids; Male; Middle Aged; Niacin; Selenium; Simvastatin; Vitamin E | 2001 |
4 other study(ies) available for simvastatin and Coronary Artery Stenosis
| Article | Year |
|---|---|
[Stable coronary heart disease--lessons from the COURAGE Study. With intensive drug therapy on the success track].
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Azetidines; Cardiovascular Agents; Combined Modality Therapy; Coronary Disease; Coronary Stenosis; Death, Sudden, Cardiac; Ezetimibe; Humans; Kaplan-Meier Estimate; Life Style; Multicenter Studies as Topic; Myocardial Infarction; Outcome and Process Assessment, Health Care; Randomized Controlled Trials as Topic; Simvastatin | 2008 |
Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway.
Topics: Androstadienes; Animals; Cholesterol; Coronary Stenosis; Drug Administration Schedule; Injections, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Simvastatin; Time Factors; Wortmannin | 2004 |
[Influence of statins on the antiplatelet effect of clopidogrel and on cardiovascular outcome in patients after coronary intervention].
Topics: Atorvastatin; Clopidogrel; Coronary Disease; Coronary Stenosis; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Simvastatin; Stents; Ticlopidine | 2008 |
Antioxidant versus lipid-altering therapy--some answers, more questions.
Topics: Antioxidants; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Coronary Stenosis; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Niacin; Simvastatin | 2001 |